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Background: The overall prevalence of complementary medicine (CM) use among adults in the United States with
diabetes has been examined both in representative national samples and in more restricted populations. However,
none of these earlier studies attempted to identify predictors of CM use to treat diabetes among the populations
sampled, nor looked for a relationship between CM use and diabetes severity.
Methods: Combining data from the 2002 and 2007 National Health Interview Survey (NHIS), we constructed a
nationally representative sample of 3,978 U.S. adults aged ≥18 years with self-reported diabetes. Both the 2002
and 2007 NHIS contained extensive questions on the use of CM. We used logistic regression to examine the
association between diabetes severity and overall CM use, as well as the use of specific categories of CM.
Results: In adults with type-2 diabetes, 30.9% used CM for any reason, but only 3.4% used CM to treat or manage
their type-2 diabetes versus 7.1% of those with type-1 diabetes. Among those using CM to treat/manage their
type-2 diabetes, 77% used both CM and conventional prescription medicine for their diabetes. The most prevalent
types of CM therapies used were diet-based interventions (35.19%, S.E. 5.11) and non-vitamin/non-mineral dietary
supplements (33.74%, S.E. 5.07). After controlling for sociodemographic factors, we found that, based on a count
of measures of diabetes severity, persons with the most severe diabetes had nearly twice the odds of using CM
as those with less severe disease (OR=1.9, 95%CI 1.2-3.01). Persons who had diabetes 10 years or more (OR=1.66,
95%CI 1.04-3.66) and those that had a functional limitation resulting from their diabetes (OR=1.74, 95%CI 1.09-2.8)
had greater odds of using CM than those not reporting these measures. No significant associations were observed
between overall CM use and other individual measures of diabetes severity: use of diabetic medications, weak or
failing kidneys, coronary heart disease, or severe vision problems.
Conclusions: Our results demonstrate that individuals with more severe diabetes are more likely to use CM
independent of sociodemographic factors. Further studies are essential to determine if CM therapies actually
improve clinical outcomes when used to treat/manage diabetes.
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Self-management is the cornerstone of overall diabetes
management [1]. Self-management of type-2 diabetes
requires complex, continual and demanding self-care
behaviors, including dietary control, exercise and fre-
quent medication. More active self-management is
generally believed to result in better metabolic control
and higher quality of life [2] while also being more cost
effective than standard pharmaceutical therapies alone
[3,4]. Yet failure to follow treatment recommendations
is reported as a serious and widespread problem in
patients with type-2 diabetes and believed to lead to dia-
betic complications such as blindness, poor wound hea-
ling, neuropathy and kidney failure.
Hernanderz et al. [5] and Paterson and Thorne [6]
have demonstrated that learning to master self-care in
diabetes is a process where the person attempts a variety
of self-care strategies according to her or his unique cir-
cumstances until discovering what is effective for their
own lifestyle and contextual situation. It has been pro-
posed that individuals with diabetes view complementary
medicine (CM) as another option for their self manage-
ment along with conventional options [7], and that indi-
viduals highly motivated to control their diabetes will try
multiple therapies available to them including CM [8].
This is consistent with numerous observations that CM
therapies are predominately used as complements to
conventional care rather than in lieu of conventional
care [9,10].
The overall prevalence of CM use among adults in the
United States with diabetes has been examined both in
representative national samples [11-13] and in more
restricted populations [7,8]. Prevalence rates in these
studies varied from about 30% to 70% depending on the
definition of CM used. Much lower rates are observed
when examining the prevalence of CM use specifically
to treat or manage diabetes – from about 20% of all
adults with diabetes in 1997 [11] to about 6.7% of all
adults with diabetes in 2002 (recalculated from [12]).
None of these studies attempted to identify predictors of
CM use to treat diabetes among the populations
sampled, nor looked for a relationship between CM use
and diabetes severity.
In the general population, a number of characteristics
are associated with CM use: gender (being female), race/
ethnicity (being non-Hispanic White), age (being middle-
aged), and education (having a college degree) to name a
few [10,14,15]. Other predictors of CM use include poor
perceived health status and the presence of multiple
health complaints [14-17]. Thus, one might hypothesize
that individuals with diabetes are more likely to use CM
if they have more severe diabetes and/or one or more
complications associated with the disease. However,
there are also data from the general population showingthat CM is associated with a number of positive health
behaviors that would be part of a wellness lifestyle [18]
including regular levels of exercise [15], nonuse of
tobacco [15,19,20], nonuse or moderation in use of alco-
hol [15,21], healthy diet choices [21] and preventive
screening [22]. It may also be that individuals oriented
toward a wellness lifestyle will be more likely to use CM
for their diabetes. The present study seeks to address
these two, not mutually exclusive hypotheses through
analysis of data from the National Health Interview Sur-
vey (NHIS). In both 2002 and 2007, the NHIS included
extensive questions on the use of a wide range of CM
therapies. The NHIS also contained a limited number of
questions on the reasons why an individual might have
chosen to use a given CM therapy. We analyzed the
responses to two of these questions to examine reasons




The data used in this study come from the 2002 and
2007 NHIS. The NHIS is an annual survey of the health
of the U.S. civilian, non-institutionalized population
conducted by the National Center for Health Statistics,
Centers for Disease Control and Prevention. The survey
uses a multi-stage clustered sample design, and over-
sampled non-Hispanic black and Hispanic persons in
both 2002 and 2007, and Asians in 2007 to allow for
more accurate national estimates of health for these
increasing minority populations.
The survey contains four main modules: Household,
Family, Sample Child, and Sample Adult. The first two
modules collect health and sociodemographic informa-
tion on each member of all families residing within a
sampled household, while the Sample Adult file includes
more specific information (e.g., health and health-related
information) obtained from a randomly chosen adult
aged 18 years or older in the household. The NHIS also
contains supplemental questions/modules on a yearly
basis. Both the 2002 and 2007 NHIS included a module
that asked about the use of various CM therapies inclu-
ding practitioner-based therapies (e.g., chiropractic and
osteopathic manipulation, massage therapy, acupunc-
ture, etc.) and self-care therapies (e.g., dietary supple-
ments, yoga, meditation, etc.). The consistency in the
sample design, weighting, and CM modalities covered in
the 2002 and 2007 NHIS made it possible to combine
data across the two samples.
In 2002, NHIS interviews were completed in 36,161
households, which yielded 93,386 persons in 36,831
families and 31,044 Sample Adults. The final house-
hold response rate was 89.6% and final sample adult
response rate was 74.3%. In 2007, NHIS interviews were
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persons in 29,915 families and 23,393 Sample Adults.
The final household response rate was 87.1% and the
final 2007 sample adult response rate was 67.8%.
Participants were asked “other than during pregnancy,
have you ever been told by a doctor or health profes-
sional that you have diabetes or sugar diabetes?” Based
on this question, in 2002, 2186 sample adults (7.04%
unweighted; 6.51% weighted) were classified as having
diabetes. Of those, 2159 (98.8% unweighted; 98.6%
weighted) had valid responses to the series of CM-
related questions. In 2007, 2036 of sample adults (8.7%
unweighted; 7.74 weighted) reported having diabetes; of
those, 1991 (97.8% unweighted; 97.9% weighted) had
valid response to the series of CM questions. Because
participants in NHIS were not categorized as having
type-1 or type-2 diabetes, participants with diabetes
diagnosed at age <25 and who were currently treated
with insulin were excluded from subsequent analysis as
probably having type-1 diabetes (N=172; Table 1). These
criteria are based on those used in previous analyses of
type-2 diabetes using NHIS data [23,24]. Thus our final
sample for analysis included 3978 participants from
2002 and 2007 combined who were coded as having
type-2 diabetes.
The surveys were approved by the National Center for
Health Statistics Institutional Review Board. Verbal or
written consent was obtained from all survey
participants.
Dependent variable
The NHIS applied the definition of CM as used by the
National Institutes of Health, National Center for Com-
plementary and Alternative Medicine at the time each
survey was designed and fielded [16,17]. Administered
to sample adults, the supplement asked a number of
questions about the use of CM therapies within the past
12 months. CM use, the dependent variable for this
study, was defined as use of any of the following in the
past 12 months: acupuncture, Ayurveda, biofeedback,
chelation therapy, chiropractic care, chiropractic or
osteopathic manipulation, energy healing therapy/Reiki,
folk medicine, hypnosis, massage therapy, movement
based therapies (Feldenkrais, Alexander technique, Pila-
tes, and Trager Psychophysical Integration), naturopathy,
herbal supplements and other non-vitamin/non-mineral
dietary supplements (NVNMDS), homeopathic treat-
ment, diet-based therapies (Vegetarian diet, Macrobiotic
diet, Atkins diet, Pritikin diet, Ornish diet and Zone diet,
and South Beach diet), traditional healers, yoga, tai chi,
qi gong, and relaxation techniques (meditation, guided
imagery, progressive relaxation, and deep breathing exer-
cises). For exploratory purposes, CM therapies were also
grouped into four discrete categories: use of only one ormore specific NVNMDS, use of only one or more types
of diet-based therapies, use of all other CM therapies,
and use of multiple CM therapies (for coding purposes,
use of multiple NVNDMS or multiple diet-based thera-
pies are counted once– e.g., use of two or more specific
herbs would be coded once as use of NVNMDS; use of
two or more specific diets would be coded once as use
of CM diets.). This last category was included as a surro-
gate measure for heavy CM users.
Independent variables
The main independent variable was based on counts of
six measures of diabetes severity: three direct measures
of diabetes severity and three known diabetes complica-
tions. An individual reporting the presence of three or
more of these individual measures was considered to
have more severe diabetes versus someone reporting less
than three. The three direct measures of greater diabetes
severity were: 1) 5 or more years since time of diagnosis;
2) use of insulin or oral hypoglycemic drugs (diabetes
prescription medications); and 3) at least one functional
limitation attributed to the diabetes. The three diabetes
complications counted were: 1) weak or failing kidneys;
2) severe vision problems; and 3) coronary heart disease.
The items chosen for the count were based on the litera-
ture where measures of diabetes severity routinely
included use of diabetes prescription drugs [25], time
since diagnosis [25], and major complications of diabetes
(even if self-reported) including kidney disease [25-27],
retinal diseases [25-27] and coronary heart disease [25-27],
but not co-morbid diseases that are not considered com-
plications of diabetes.
The coding for weak/failing kidneys and coronary
heart disease were based on “yes” responses to the fol-
lowing questions in the NHIS: “Have you ever been told
by a doctor or other health professional that you have:
coronary heart disease . . . weak or failing kidneys.” Indi-
viduals were coded as having severe vision problems if
either they responded yes to the NHIS question “Do you
have trouble seeing even when wearing glasses or con-
tacts” OR had a functional limitation (see below) result-
ing from “vision problem/problem seeing”.
Also included in some of the published studies exam-
ining diabetes severity were diabetes-related functional
limitations [27,28]. In the present study, the measure of
functional limitation for diabetes was based on the fol-
lowing sequential questions from the NHIS core: “The
next questions ask about difficulties you may have doing
certain activities because of a HEALTH PROBLEM. By
“health problem” we mean any physical, mental, or emo-
tional problem or illness (not including pregnancy).”
The questionnaire goes on to ask about 12 activities
such as walking one-quarter mile, grasping small objects,
pushing something heavy, or participating in various
Table 1 Characteristics of sample adults with Type 1 and Type 2 diabetes: data from the 2002 and 2007 NHIS
Type 1 N=172* Type 2 N=3978*
% of adult sample (S.E.)† 0.32 (0.03) 6.83 (0.14)
% of individuals with diabetes (S.E.)† 4.5 (.4) 95.5 (.4)
Weighted sample 689,758 14,642,272
N* % S.E.‡ N* %† S.E.‡
Count of diabetes severity measures§
0-2 87 49.99 4.42 2835 76.66 0.84
>=3 84 50.01 4.79 945 23.34 0.84
DM Duration
1-< 5 years 10 5.04 2.26 1393 37.24 0.94
5-<10 years 12 6.72 2.13 856 23 0.95
>= 10 years 150 88.25 3.03 1610 39.77 1
Diabetes Medication use
None 0 0 580 16.08 0.76
Any use 172 100 3387 83.92 0.76
Functional limitation
No 125 76.47 3.87 3209 83.13 0.68
Yes 46 23.53 3.87 721 16.87 0.68
Weak or failing Kidneys
No 149 85.55 3.53 3690 93.25 0.5
Yes 23 14.45 3.53 279 6.75 0.5
Severe Vision Problem
No 118 69.47 4.43 3026 78.86 0.79
Yes 53 30.53 4.43 910 21.14 0.79
Gender
Male 73 44.15 4.49 1788 49.73 1.01
Female 99 55.85 4.49 2190 50.27 1.01
Age group
Age 18-44 yrs 95 57.82 4.73 473 12.68 0.7
Age 45-64 yrs 56 32.05 4.42 1726 47 0.98
Age 65+ yrs 21 10.13 2.43 1779 40.32 0.9
Education
Less than high school 36 21.39 4.16 1228 27.24 0.86
At least high school 135 78.61 4.16 2695 72.76 0.89
Race/ethnicity
Non-Hispanic white 101 64.7 4.39 2255 65.26 0.99
Non-Hispanic black 32 15.67 3.38 822 15.69 0.68
Hispanic 30 14.85 3.07 687 12.48 0.62
Other races 9 4.78 1.75 214 6.56 0.61
Region of residence
Northeast 24 15.36 3.68 661 16.06 0.78
Midwest 44 25.14 3.9 868 23.35 1.02
South 69 40.82 4.71 1617 40.52 1.09
West 35 18.69 3.23 832 20.07 0.9
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Table 1 Characteristics of sample adults with Type 1 and Type 2 diabetes: data from the 2002 and 2007 NHIS
(Continued)
Health Insurance
Public Insurance 56 31.61 4.51 1429 30.17 0.9
Private Insurance 99 59.06 4.55 2172 60.21 1
No Insurance 16 9.33 2.81 366 9.62 0.62
Other health conditions||
0-2 139 83.49 139 2774 70.1 0.91
3 or more 33 16.51 33 1204 29.9 0.91
BMI Level
BMI 0 - < 25 63 37.24 4.64 687 16.01 0.67
BMI 25 - < 30 36 19.65 3.65 1251 31.96 0.94
BMI >= 30 73 43.11 4.73 2040 52.03 0.96
Hypertension
No 97 57.32 4.71 1614 42.6 0.98
Yes 75 42.68 4.71 2350 57.4 0.98
Coronary heart disease
No 154 89.57 2.69 3489 88.12 0.64
Yes 19 10.43 2.69 458 11.88 0.64
Smoking status
Current 30 20.42 4.25 618 16.23 0.76
Former smoker 34 18.09 3.2 1382 35.49 0.98
Never smoker 107 61.49 4.73 1953 48.28 0.99
Alcohol use
Never/none 56 30.21 4.27 1242 29.01 0.91
Any 115 69.97 4.27 2703 70.99 0.91
Anxiety or Depression
No 124 72.26 4.39 2900 73.58 0.88
Yes 48 27.74 4.39 1068 26.42 0.88
Vigorous leisure activity
Unable to do or none 110 66.54 4.56 2877 77.44 0.95
Any per week 50 33.46 4.56 742 22.55 0.95
Perceived health status
Fair/poor 84 53.14 4.61 1771 43.28 1
Exc/VG/Good¶ 88 46.86 4.61 2204 56.72 1
Any CM Use to Treat or Manage Diabetes 13 7.06 2.27 141 3.43 0.37
* The unweighted number of participants belonging to each category.
† The denominator used in the calculation of percentages was the number of adults with type-2 Diabetes, defined as all participants with diabetes excluding
those who were both diagnosed at age <25 and were currently being treated with insulin, who were classified as having type-1 diabetes. Estimates were age
adjusted using the projected 2000 U.S. population as the standard population and using four age groups: 18–24 years, 25–44 years, 45–64 years, and 65 years
and over.
‡ Standard Errors.
§ Based on the following six measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation
attributed to the diabetes, weak or failing kidneys, Coronary Heart Disease, and severe vision problems.
|| Includes all health conditions included in the NHIS except weak or failing kidney, severe vision problems, coronary heart disease, hypertension, and anxiety
or depression.
¶ Excellent/Very Good/Good.
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http://www.biomedcentral.com/1472-6882/12/193social activities. Difficulties with any of these 12 activities
would elicit the following follow-up question: “What
condition or health problem causes you to have difficulty
with [problem 1, problem 2 or problem 3]”. If the par-
ticipant reported that any specific functional limitation
resulted from diabetes, or vision problems/problems see-
ing, for the current analysis they were coded as having
a functional limitation associated with diabetes, or a
severe vision problem, respectively.
When developing our list of diabetes severity measures
to count, we explored the correlational relationships
among our dichotomous variables through the tau statis-
tic, which measures the amount of concordance and
discordance among variables. For all 15 comparisons we
made (each individual variable in the count vs. every
other individual variable in the count), the calculated
taus’s were all less than 0.2, indicating that there was
substantial discordance among the variables (that is,
relatively low collinearity).
The literature shows that while anxiety/depression is
seen as a risk factor for diabetes in many individuals, it
is a complication of diabetes in others [29,30]. As such,
in sensitivity analysis, we also examined the impact of
adding depression to the co-morbidities to be included
in the diabetes severity count. The calculated taus’s
comparing anxiety/depression to every other measures
used in the count were all less than 0.2.
Control variables
Variables often associated with CM use among NHIS
participants [15-17,31] were included in these analyses
as control variables. These included sex, age (18–44; 45–
64; 65+), education (<high school, HS or greater), race/
ethnicity (non-Hispanic white, non-Hispanic black, His-
panic, other), region (Northeast, Midwest, South, West),
health insurance status (no insurance, public insurance,
private insurance), hypertension (yes, no), other health
conditions (excluding weak/failing kidneys and severe vi-
sion problems, hypertension, and anxiety/depression; 0–
2 versus 3 or more), perceived health status (fair/poor,
excellent/very good/good), ability to perform vigorous
leisure activity (unable to do, any per week), smoking
status (never, former, or current), alcohol consumption
(never/none, any), and BMI (0-<25 kg/m2; 25-<30 kg/m2;
>=30 kg/m2). For our coding of alcohol use, we have
employed the CDC definition of alcohol abstainer based
on responses to two questions: “In ANY ONE YEAR, have
you had at least 12 drinks of any type of alcoholic beve-
rage?” and “In your ENTIRE LIFE, have you had at least
12 drinks of any type of alcoholic beverage?”.
Reasons for CM use
We conclude these analyses by presenting data on
whether individuals who use CM to treat/manage theirtype-2 diabetes are dissatisfied with their conventional
care. Specifically, we analyze data from two questions in
the NHIS: “DURING THE PAST 12 MONTHS, did you
use {given CM therapy}. . .Because medical treatments
did not help; Because medical treatments were too
expensive.” Chi square analysis was used to identify sig-
nificant associations between these reasons and the va-
rious measures of diabetes severity.
Statistical analysis
Descriptive statistics (means, percentages) for the char-
acteristics of individuals coded as having type-2 diabetes
were calculated for any CM use, and for each of the four
CM categories. Chi-square analysis was used to test bi-
variate associations between the independent/control
variables and any CM use, as well as for each of the four
CM categories.
Multiple logistic regression was used to assess the rela-
tionships between the count measure of diabetes severity
and use of CM in the past 12 months, after adjusting for
control variables. Only control variables associated with
CM use at p< 0.1 level in chi-square analysis were
retained as control variables in the adjusted regression
model. In addition, to control for any secular trends, the
year of the survey (2002 or 2007) was forced into all
adjusted models. As secondary analyses, we also individu-
ally explored the associations between each of the six
measures of diabetes severity (plus anxiety/depression in
sensitivity analysis) with use of CM.
For the multiple logistic regression models, there was
no evidence of collinearity; inspections of tolerance
values, condition indices, and variance inflation factors,
suggested we had employed properly specified hetero-
skedastic models.
All estimates, including those of CM prevalence,
were generated using SUDAAN software (version 10, Re-
search Triangle Institute, Research Triangle Park, N.C.)
that accounts for complex sample designs such as that
used by the NHIS. To ensure representation of the U.S.,
civilian, non-institutionalized population age 18 years and
over, all estimates (percentages, odds ratio, standard
errors, 95% confidence limits) were weighted using the
NHIS sample adult record weight.
Sensitivity analyses
Based on previous analyses of NHIS data and other
population-based data [23,24,32,33] and taking into ac-
count the growing rate of type-2 diabetes in youth, we
had set our criteria for probable type-1 diabetes as parti-
cipants with diabetes diagnosed at age <25 and who
were currently treated with insulin. However, based on
more recent data, it can be argued that a lower age cut-
off is warranted [34-37]. Therefore, we have performed
sensitivity analyses where we have reduced that age
Table 2 Characteristics of adults who used complementary medicine (CM)* to treat their type-2 diabetes
Did not use CM to treat/manage their diabetes Used CM to treat/manage their diabetes
N† Percent‡ S.E.§ N† Percent‡ S.E.§
All adults with type-2 diabetes 3873 96.57 0.37 141 3.43 0.37
N† Percent|| S.E. § N† Percent|| S.E. § P-value¶
Count of diabetes severity measures#
0-2 measures 2738 76.82 0.85 97 72.25 4.29 0.284
>=3 measures 904 23.18 0.85 41 27.75 4.29
Diabetes duration
1-< 5 years 1348 37.2 0.96 45 38.29 5.35 0.067
5-<10 years 835 23.28 0.98 21 15.11 3.58
>= 10 years 1536 39.52 1.02 74 46.6 5.33
Diabetes medication use
None 554 15.83 0.77 26 23.08 4.9 0.16
Any 3273 84.17 0.77 114 76.92 4.9
Functional limitation
No 3105 83.34 0.7 104 77.34 3.7 0.104
Yes 684 16.66 0.7 37 22.66 3.7
Weak/failing kidneys
No 3561 93.28 0.49 129 92.38 2.76 0.741
Yes 268 6.72 0.49 11 7.62 2.76
Coronary heart disease
No 3359 87.95 0.66 130 92.97 2.27 0.044
Yes 447 12.05 0.66 11 7.03 2.27
Severe vision problems
No 2921 78.91 0.8 105 77.21 4.29 0.706
Yes 874 21.09 0.8 36 22.71 4.29
Anxiety or depression
No 2800 73.62 0.89 100 72.59 4.82 0.823
Yes 1027 26.38 0.89 41 27.41 4.82
Gender
Male 1725 49.83 1.04 63 46.95 4.79 0.56
Female 2112 50.17 1.04 78 53.05 4.79
Age group
Age 18-44 yrs 451 12.54 0.71 22 16.65 4.02 0.04
Age 45-64 yrs 1653 46.71 0.99 73 55.11 4.97
Age 65+ yrs 1733 40.75 0.91 46 28.24 4.34
Education
Less than high school 1190 27.38 0.89 38 23.4 4.17 0.355
At least high school 2594 72.62 0.89 101 76.6 4.17
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Table 2 Characteristics of adults who used complementary medicine (CM)* to treat their type-2 diabetes (Continued)
Income
$0-$34,999 2334 50.57 1.11 81 44.41 5.37 0.337
$35,000-$74,999 1035 32.05 1.15 40 29.08 5.03
$75,000 + 468 17.38 0.99 20 26.51 5.8
Race/ethnicity
NH White 2183 65.46 0.99 72 59.5 5.46 0.059
NH Black 802 15.9 0.68 20 9.93 2.7
Hispanic 650 12.25 0.64 37 19.09 3.42
Other races 202 6.39 0.59 12 11.48 4.32
Region of residence
Northeast 648 16.27 0.78 13 10.09 3.28 0.01
Midwest 846 23.6 1.05 22 16.44 3.9
South 1565 40.75 1.11 52 33.89 4.95
West 778 19.38 0.9 54 39.58 5.47
Health insurance
Public insurance 1390 30.43 0.91 39 22.57 4.02 0.135
Private insurance 2096 60.09 1.02 76 63.55 4.91
No insurance 342 9.47 0.63 24 13.88 3.46
Other health conditions **
0-2 2694 70.54 0.93 80 57.84 5.41 0.017
3 or more 1143 29.46 0.93 61 42.16 5.41
BMI level
BMI 0 - < 25 673 16.3 0.68 14 7.65 2.25 0.002
BMI 25 - < 30 1210 32.08 0.86 41 28.71 4.94
BMI >= 30 1954 51.62 0.98 86 63.64 5.08
Hypertension
No 1544 54.41 1 70 48 5.19 0.297
Yes 2279 57.59 1 71 52 5.19
Smoking status
Current 605 16.4 0.77 13 11.61 3.99 0.441
Former smoker 1329 35.52 0.99 53 34.51 4.69
Never smoker 1878 48.08 1 75 53.89 5.33
Alcohol use
Never/none 1202 29.19 0.94 40 23.97 3.91 0.21
Any 2604 70.81 0.94 99 76.03 3.91
Vigorous leisure activity
Unable to do or none 2784 77.82 0.95 93 67.08 5.79 0.086
Any per week 706 22.18 0.95 36 32.92 5.79
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Table 2 Characteristics of adults who used complementary medicine (CM)* to treat their type-2 diabetes (Continued)
Perceived health status
Fair/poor 1715 43.74 1.02 56 30.35 4.58 0.012
Exc/VG/Good†† 2119 56.26 1.02 85 69.65 4.58
* CM use, the dependent variable for this study, was defined as use of any of the following in the past 12 months: acupuncture, Ayurveda, biofeedback, chelation
therapy, chiropractic care, chiropractic or osteopathic manipulation, energy healing therapy/Reiki, folk medicine, hypnosis, massage therapy, movement based
therapies, naturopathy, herbal supplements and other non-vitamin/non-mineral dietary supplements (NVNMDS), homeopathic treatment, diet-based therapies,
traditional healers, yoga, tai chi, qi gong, and relaxation techniques.
† The unweighted number of participants belonging to each category.
‡ The denominator used in the calculation of percentages was the number of adults with type-2 Diabetes, defined as all participants with diabetes excluding
those who were both diagnosed at age <25 and were currently being treated with insulin, who were classified as having type-1 diabetes. Estimates were age
adjusted using the projected 2000 U.S. population as the standard population and using four age groups: 18–24 years, 25–44 years, 45–64 years, and 65 years
and over”.
§ Standard Errors.
|| For each individual characteristic, the denominator used in the calculation of percentages was the number of adults with type-2 Diabetes for whom a response
was recorded for the particular characteristic. Estimates were age adjusted using the projected 2000 U.S. population as the standard population and using four
age groups: 18–24 years, 25–44 years, 45–64 years, and 65 years and over”.
¶ Chi-square analyses comparing individuals with Type-2 diabetes who used CM to treat/manage their diabetes versus those not using CM to treat/manage
their diabetes.
# Based on the following six measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation
attributed to the diabetes, weak or failing kidneys, Coronary Heart Disease, and severe vision problems.
** Includes all health conditions included in the NHIS except weak or failing kidney, severe vision problems, coronary heart disease, hypertension, and anxiety
or depression.
†† Excellent/Very Good/Good.
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ally capturing for analysis most, if not all, individuals
with type-2 diabetes in our NHIS sample. Frequencies,
chi sq and logistic regression data for this sensitivity
analysis are presented.
Results
We found that 7.2% (S.E. 0.14) of surveyed adults
reported having physician diagnosed diabetes. This
equates to roughly 15.3 million adults in the United
States. Of these, 95.5% (S.E. 0.4), or 14.6 million, were
coded as having type-2 diabetes. The majority of indivi-
duals with type-2 diabetes had the disease longer than
5 years, were taking either insulin or oral hypoglycemic
medication, did not have a functional limitation related
to diabetes, did not have weak/failing kidneys or severe
vision problems, were at least 45 years old, had greater
than a high school education, were Non-Hispanic
whites, had private health insurance, were overweight or
obese, had hypertension but not coronary heart disease,
had smoked tobacco and consumed alcohol at some
point in their lives, were not depressed or anxious, and
were unable to perform vigorous leisure activity but
nevertheless considered themselves in at least good
health (Table 1). About equal numbers of men and
women had type-2 diabetes. In contrast, individuals with
type-1 diabetes predominately had their diabetes more
than 10 years, were under 45 years of age, did not have a
functional limitation related to diabetes, did not have
weak/failing kidneys, severe vision problems, hyperten-
sion, coronary heart disease or depression, yet consid-
ered their health as only fair or poor (Table 1).
Consistent with the literature, we found that 30.9%
(S.E. 0.96) of individuals with type-2 diabetes used CMfor some reason, equating to roughly 4.4 million adults
(data not shown). However, only 3.43% (S.E. 0.37) of
individuals with type-2 diabetes used CM specifically to
treat or manage their diabetes versus 7.06% of those with
type-1 diabetes (Table 1). Among those using CM to
treat/manage their type-2 diabetes, 63% have had their
diabetes for more than five years, and 77% used both
CM and conventional prescription medicine for their
diabetes (Table 2). Only a quarter of individuals using
CM to treat/manage their type-2 diabetes reported a
functional limitation resulting from their diabetes, severe
vision problems or anxiety/depression (Table 2). Very
few individuals using CM for their diabetes reported
weak/failing kidneys or coronary heart disease (Table 2).
Within the group using CM to treat or manage their
diabetes, we observed that a number of sociodemo-
graphic and health status variables were associated with
CM use at p<0.1 (Table 2): age, race/ethnicity, region of
residence, number of co-morbid conditions, BMI level,
the ability to perform vigorous leisure activity at least
once per week and perceived health status. These va-
riables were included in all adjusted logistic regression
models as covariates.
Diabetes severity
Table 3 shows the results from unadjusted and adjusted
logistic regression models fitted for our count measure
of disease severity. We found that more severe disease
was associated with CM use, with someone exhibiting
three or more measures of diabetes severity having
almost twice the adjusted odds of using CM as someone
with less than three measures. To explore this finding in
more detail, we examined the association between CM
use and each measure of diabetes severity contributing
Table 3 Associations of diabetes severity with use of complementary medicine (CM)* to treat/manage type-2 diabetes
UOR† 95% CI‡ AOR§ 95% CI‡
Count of diabetes severity measures||
0-2 measures ref Ref
>=3 measures 1.27 .83-1.94 1.90 1.2-3.01
Individual measures of diabetes severity
DM duration
1-< 5 years ref Ref
5-<10 years 0.63 .34-1.18 0.70 .36-1.35
>= 10 years 1.15 .71-1.85 1.66 1.04-2.66
Diabetes medication use
None ref Ref
Any 0.63 .36-1.06 0.66 .36-1.19
Functional limitation
No ref Ref
Yes 1.47 .95-2.25 1.74 1.09-2.80
Weak/failing kidneys
No ref Ref
Yes 1.15 .53-2.47 1.46 .60-3.53
Coronary Heart Disease
No ref Ref
Yes 0.55 .28-1.10 0.87 .43-1.74
Severe vision problems
No ref Ref
Yes 1.1 .68-1.78 1.48 .85-2.57
* CM use, the dependent variable for this study, was defined as use of any of the following in the past 12 months: acupuncture, Ayurveda, biofeedback, chelation
therapy, chiropractic care, chiropractic or osteopathic manipulation, energy healing therapy/Reiki, folk medicine, hypnosis, massage therapy, movement based
therapies, naturopathy, herbal supplements and other non-vitamin/non-mineral dietary supplements (NVNMDS), homeopathic treatment, diet-based therapies,
traditional healers, yoga, tai chi, qi gong, and relaxation techniques.
† unadjusted or crude odds ratio.
‡ 95% confidence interval.
§ Adjusted Odds Ratio. The model controls for socio-demographic and health status variables significantly associated (p < 0.1) with the dependent variables in
Table 2: race/ethnicity, region of residence, number of co-morbid conditions, BMI level, the ability to perform vigorous leisure activity at least once per week and
perceived health status, as well as for year of survey.
|| Based on the following six measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation
attributed to the diabetes, weak or failing kidneys, Coronary Heart Disease, and severe vision problems.
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nificant associations were seen in the unadjusted ana-
lyses (Table 3), the odds ratio point estimates for use of
diabetes prescription medications and coronary heart
disease suggest negative associations with CM use, while
the point estimates for the other four measures suggest
positive associations with CM use. In the adjusted
model, those individuals whose diabetes was diagnosed
10 or more years ago had 66% greater odds of using CM
than those diagnosed within the last five years, while
those individuals with a functional limitation resulting
from their diabetes had 74% greater odds of using CM
than individuals without a limitation (Table 3). Adjusting
for covariates in the logistic regression model did not
substantially change the odds ratio point estimates for
the other measures of diabetes severity. Simultaneouslyadding all individual measures of diabetes severity to the
adjusted model at the same time also did not substan-
tially change any of these findings (data not shown).
Control variables
Table 4 presents unadjusted and adjusted odds ratios for
the control variables included in the regression models.
In both the unadjusted and adjusted analyses, residing in
the West versus other parts of the country, having an
unhealthily high BMI (>=30), and having three or more
comorbidities (other than weak/failing kidneys, severe
vision problems, coronary heart disease, or hyperten-
sion) were significantly associated with higher CM use,
while having a fair or poor perceived health status was
associated with significantly lower CM use (Table 4).
Whereas in the unadjusted analysis Hispanic respondents
Table 4 Associations of socio-demographic and health
status variables with use of complementary medicine
(CM)* to treat/manage type-2 diabetes
UOR† 95% CI‡ AOR§ 95% CI‡
Age group
Age 18–44 yrs Ref Ref
Age 45–64 yrs 0.89 .48-1.63 1.16 .56-2.37
Age 65+ yrs 0.52 .27-.99 0.76 .36-1.59
Race/ethnicity
NH White Ref Ref
NH Black 0.69 .38-1.26 0.76 .39-1.46
Hispanic 1.71 1.05-2.81 1.39 .83-2.33
Other races 1.98 .83-4.72 1.49 .63-3.55
Region of residence
Northeast 0.3 .14-.66 0.30 .14-.63
Midwest 0.34 .18-.65 0.32 .16-.62




3 or more 1.75 1.12-2.73 1.72 1.01-2.93
BMI Level
BMI 0 - < 25 Ref ref
BMI 25 - < 30 1.91 .93-3.93 1.91 .91-4.02
BMI >= 30 2.63 1.38-5.02 2.32 1.12-4.81
Vigorous leisure activity
Unable to do or none 0.58 .34-.98 0.68 .40-1.13
Any per week Ref ref
Perceived health status




2007 NA 0.66 .42-1.04
* CM use, the dependent variable for this study, was defined as use of any of
the following in the past 12 months: acupuncture, Ayurveda, biofeedback,
chelation therapy, chiropractic care, chiropractic or osteopathic manipulation,
energy healing therapy/Reiki, folk medicine, hypnosis, massage therapy,
movement based therapies, naturopathy, herbal supplements and other
non-vitamin/non-mineral dietary supplements (NVNMDS), homeopathic
treatment, diet-based therapies, traditional healers, yoga, tai chi, qi gong,
and relaxation techniques.
† unadjusted or crude odds ratio.
‡ 95% confidence interval.
§ Adjusted Odds Ratio. The model controls for socio-demographic and health
status variables significantly associated (p < 0.1) with the dependent variable
in Table 2: race/ethnicity, region of residence, number of co-morbid
conditions, BMI level, presence of coronary heart disease, the ability to
perform vigorous leisure activity at least once per week and perceived health
status, as well as for year of survey.
|| Excellent/Very Good/Good.
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than were non-Hispanic whites, those differences became
non-significant in multivariate analyses. Similarly, after
adjusting for the other variables, the negative relation-
ships between CM use and being at least 65 years of
age, and CM use and the inability to perform vigorous
activity disappeared, though the point estimates remained
above 1.0.
Types of CM therapies used
In exploratory analyses, we examined the prevalence of
use of four categories of CM to treat type-2 diabetes,
and their associations with diabetes severity. Of the four
categories, diet-based interventions (35.19%, S.E. 5.11)
were the most used group of therapies followed closely by
non-vitamin/non-mineral dietary supplements (NVNMDS)
(33.74%, S.E. 5.07), then more distantly by therapies cate-
gorized as “other” (21%, S.E> 4.55). Relatively few indivi-
duals used multiple CM therapies (9.86%, S.E. 3.02) to
treat or manage their diabetes. Of the measures of dia-
betes severity, only use of diabetes prescription medi-
cations varied significantly by CM category (Table 5).
Individuals who used only NVNMDS were more likely
to use diabetes prescription medications than did indivi-
duals who used multiple CM therapies.
A total of 12 different NVNMDS were used by indivi-
duals to treat or manage their diabetes: glucosamine,
fiber or psyllium, fish oil or omega 3, flax seed oil, garlic
supplements, ginseng, green tea pills, saw palmetto,
cranberry pills, evening primrose, milk thistle, and leci-
thin. However, the numbers using each agent were too
small to permit any demographic analyses.
Within the “Other” CM category, individuals used nine
different therapies to treat or manage their diabetes: acu-
puncture, biofeedback, folk medicine, chiropractic care,
homeopathy, naturopathy, relaxation techniques, tai chi,
and yoga. Too few individuals used any specific “other”
therapy to permit detailed analyses.
Reasons for CM use
Of those who used CM to treat or manage their dia-
betes, 20.13% (S.E. 3.87) said they did so because they
believed conventional treatments did not help, while
21.3% (S.E. 4.17) did so because they felt conventional
medical treatments were too expensive. No associations
were seen between the response to these questions and
measures of diabetes severity (data not shown).
Sensitivity analyses
Sensitivity analyses are presented in Table 6. While
addition of anxiety/depression (as a diabetes complica-
tion) to the count measure of disease severity produced
a small reduction in the strength of association between
disease severity and use of CM (from AOR= 1.9 to
Table 5 Use of selected complementary medicine (CM) categories to treat/manage type-2 diabetes, by selected
measures of diabetes severity
CM Diets* n=44 NVNMDS† n=55 Other CM‡ n=29 Multi CM§ n=13
Percent|| S.E.¶ Percent|| S.E.¶ Percent|| S.E.¶ Percent|| S.E.¶
TOTAL 35.19 5.11 33.74 5.07 21.21 4.55 9.86 3.02
Percent# S.E. ¶ Percent# S.E. Percent# S.E. ¶ Percent#7 S.E. ¶ P-value††
Count of diabetes severity measures ‡‡
0-2 81.97 6.85 66.86 6.7 56.69 11.7 88.89 10.4 0.195
>=3 18.09 6.85 33.14 6.7 43.31 11.7 11.11 10.4
DM duration(years)
1-< 5 40.5 6.96 30.76 7.5 34.57 13.8 63.31 15.3 0.109
5-<10 23.52 7.93 16.9 6.6 3.27 2.45 4.63 4.64
>= 10 35.89 8.77 52.34 7.98 62.16 13.5 32.06 14.5
Diabetes medication use
None 36.25 10.4 7.99 3.57 5.75 5.6 64.71 13.6 0.009
Any 63.75 10.4 92.01 3.57 94.25 5.6 35.29 13.6
Functional limitation
No 84.88 5.21 78.88 5.24 60.37 11.6 81.73 12.3 0.25
Yes 15.12 5.21 21.12 5.24 39.63 11.6 18.27 12.3
Weak/failing kidneys
No 89.66 6.02 90.36 4.54 98.26 1.76 96.23 4.4 0.304
Yes 10.34 6.02 9.64 4.54 1.74 1.76 3.77 4.4
Coronary Heart Disease
No 94.77 3.09 91.08 4.39 89.7 6 100 0 0.139
Yes 5.23 3.09 8.92 4.39 10.3 6 0 0
Severe vision problems
No 74.67 8.21 82.59 4.75 69.29 10.0 85.7 9.88 0.603
Yes 25.33 8.21 17.41 4.75 30.71 10.0 14.3 9.88
Anxiety or Depression
No 75.38 7.78 79.01 5.66 57.35 13.3 73.45 12.1 0.609
Yes 24.62 7.78 20.99 5.66 42.65 13.3 26.55 12.1
* Vegetarian diet, Macrobiotic diet, Atkins diet, Pritikin diet, Ornish diet, Zone diet, and South Beach.
† herbal supplements and other non-vitamin/non-mineral dietary supplements.
‡ acupuncture, Ayurveda, biofeedback, chelation therapy, chiropractic care, chiropractic or osteopathic manipulation, energy healing therapy/Reiki, folk medicine,
hypnosis, massage therapy, movement based therapies, naturopathy, homeopathic treatment, traditional healers, yoga, tai chi, qi gong, and relaxation techniques
§ Any combination of multiple CM therapies.
|| The denominator used in the calculation of percentages was the number of adults with type-2 diabetes who used any CM therapy to treat/manage their
diabetes. Estimates were age adjusted using the projected 2000 U.S. population as the standard population and using four age groups: 18–24 years, 25–44 years,
45–64 years, and 65 years and over.
¶ Standard Errors.
# The denominator used in the calculation of percentages was the number of adults with type-2 Diabetes who used the indicated type of CM therapy. Estimates
were age adjusted using the projected 2000 U.S. population as the standard population and using four age groups: 18–24 years, 25–44 years, 45–64 years, and
65 years and over.
†† Chi-square analyses comparing use of the indicated CM therapies in individuals with Type-2 diabetes who use CM to treat/manage their diabetes
‡‡ Based on the following five measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation
attributed to the diabetes, weak or failing kidneys, and severe vision problems.
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nificant. As an individual measure of diabetes severity,
anxiety/depression was not associated with CM use.
Stepping down the age cutoff for diagnosis of diabetes
from <25 years of age to <10 years of age produced a
slight reduction in the strength of the associationbetween diabetes severity and use of CM (AOR=1.9 to
AOR 1.79) that remained statistically significant.
Discussion
To our knowledge, this is the first report to examine the
association between the use of CM and severity of
Table 6 Sensitivity Analyses of associations between diabetes severity and use of complementary medicine (CM)* to
treat/manage type-2 diabetes
UOR† 95% CI‡ AOR§ 95% CI‡
Analysis includes all individuals coded as having type-2 diabetes
Count of diabetes severity measures includes anxiety or depression
0-2 measures Ref Ref
>=3 measures 1.16 0.77-1.77 1.64 1.07-2.52
Anxiety or Depression
No Ref Ref
Yes 1.05 .65-1.7 1.16 .64-2.12
Alternate coding strategies for type-2 diabetes which vary the age at which diabetes was diagnosis
<20 years old
Original count of diabetes severity measures||
0-2 measures ref Ref
>=3 measures 1.21 .80-1.83 1.78 1.13-2.81
<15 years old
Original count of diabetes severity measures||
0-2 measures ref Ref
>=3 measures 1.18 .78-1.78 1.75 1.11-2.76
<10 years old
Original count of diabetes severity measures||
0-2 measures ref Ref
>=3 measures 1.25 .84-1.85 1.79 1.14-2.80
* CM use, the dependent variable for this study, was defined as use of any of the following in the past 12 months: acupuncture, Ayurveda, biofeedback, chelation
therapy, chiropractic care, chiropractic or osteopathic manipulation, energy healing therapy/Reiki, folk medicine, hypnosis, massage therapy, movement based
therapies, naturopathy, herbal supplements and other non-vitamin/non-mineral dietary supplements (NVNMDS), homeopathic treatment, diet-based therapies,
traditional healers, yoga, tai chi, qi gong, and relaxation techniques.
† unadjusted or crude odds ratio.
‡ 95% confidence interval.
§ Adjusted Odds Ratio. The model controls for socio-demographic and health status variables significantly associated (p < 0.1) with the dependent variables in
Table 2: race/ethnicity, region of residence, number of co-morbid conditions, BMI level, the ability to perform vigorous leisure activity at least once per week and
perceived health status, as well as for year of survey.
|| Based on the following six measures: 5 or more years since time of diagnosis, use of insulin or oral hypoglycemic drugs, at least one functional limitation
attributed to the diabetes, weak or failing kidneys, Coronary Heart Disease, and severe vision problems.
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sample. We found that only a small proportion of indi-
viduals coded with type-2 diabetes used CM to treat
or manage their diabetes (3.4%). However, in this
small cohort, persons with the most severe disease (as
assessed by having 3 or more measures of diabetes
severity) had almost twice the odds of using a comple-
mentary therapy as those with less severe disease. This
association was relatively insensitive to the inclusion of
anxiety/depression as a diabetes complication, and to
changes in the age at diagnosis cutoff for differentiating
type-1 and type-2. Furthermore, we found that persons
who had diabetes 10 or more years and those who had a
functional limitation resulting from their diabetes were
more likely to use at least one CM therapy. Our study
could not determine whether the use of CM is a direct
result of diabetes severity or whether other unmeasured
and uncontrolled factors motivate use.While our observation that 30.9% of individuals with
type-2 diabetes used CM for any reason is consistent
with early reports [11,12], our finding that only 3.4% of
individuals with type-2 specifically use CM to treat or
manage their diabetes is substantially lower than that
reported by Yeh et al., 2002 (20%)[11]. Although it is
possible some of these discrepancies reflect real changes
in use over time, it is more likely the discrepancies
reflect methodological differences in the two surveys. In
calculating their prevalence of CM use in 1997, Yeh and
colleagues [11] included four types of therapies not
included in the present analyses: folk remedies (2.9%)
(included in the 2002 but not 2007 NHIS), commercial
diets (6.4%), high dose vitamins (1.7%) and self-help
groups (2.3%). In addition, Yeh et al. [11] found higher
use of herbal medicines to treat or manage diabetes then
we did for NVNMDS in the present study, 6.7% vs. 1.1%,
respectively. This discrepancy is most likely explained by
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on use of “herbal medicine”, while in the NHIS partici-
pants were asked if they used specific NVNMDS on
a list.
While the inverse association between the use of CM
and the use of prescription diabetes medications failed
to reach significance in either the unadjusted or adjusted
logistic regression models, some comment is still war-
ranted given concerns of herb-drug interactions [38] or
the substitution of CM therapies for proven conven-
tional therapies for diabetes [39]. There are two compe-
ting interpretations of our observation: 1) those using
CM are more likely to forego needed conventional treat-
ment; or 2) individuals with less severe disease not
requiring medical interventions are more likely to use
CM. When examining CM categories, we observed that
diabetes medication use predominates in CM users
across categories except in participants using multiple
CM therapies (only 35.3% of whom used diabetic medi-
cations). Except for multiple CM users, the present CM
category data are consistent with a regional survey of
older rural adults diagnosed with diabetes (N= 679)[40],
where no difference in diabetes medication adherence
was found between those who used CM and those
who didn’t.
Consistent with our observation that most individuals
(77%) who use CM for their diabetes also use conven-
tional diabetes prescription medications are the data of
Garrow and Egede [41] who found that individuals with
diabetes using CM (for any reason) were more likely to
receive regular preventive care than were individuals
with diabetes who did not use CM. These quantitative
findings are supported by qualitative research [8] sug-
gesting that individuals with diabetes who try CM were
highly motivated to control their diabetes and to try all
methods available to them, and did not use CM as a
substitute for conventional care.
We are aware of only one other article that discussed
demographic characteristics of individuals in the United
States using CM specifically to treat or manage their dia-
betes [7]. In this survey of rural older adults in North
Carolina, it was found that in those using CM for their
diabetes, home remedies were the prevalent type of CM
therapy used, with their use associated with race/ethnicity
and the number of co-morbidities. In the present study,
we also found that the number of co-morbidities was
associated with the overall use of CM but did not see a re-
lationship between CM use and race/ethnicity. Unfortu-
nately, the NHIS did not specifically look at use of home
remedies, which may explain the differences in our find-
ings from Arcury et al. [7].
Our analyses revealed an interesting paradox in that
persons with more severe diabetes are more likely to use
CM to treat/manage their diabetes, but persons withpoorer perceived general health status were less likely to
use CM (OR 0.56, 95% CI .33-.86). Using data from
the 2007 NHIS, Nguyen and colleagues [42] observed a
similar paradox in the general population where indi-
viduals “using CAM were more likely to have chronic ill-
ness . . . yet also were more likely to report that their
health status was excellent and better than the prior
year.” Nguyen et al., [42] suggested two possible reasons
for the paradox, both of which also apply to our ana-
lyses: 1) different timeframes for the health status ques-
tions (current status) and illness self-reports (previous
12-months); 2) positive expectations of CM use may
positively impact perceived health status.
We found that relatively few individuals with diabetes
who used CM for their diabetes used more than one
type of CM therapy (<10%). This is in contrast to the
general population in 2007 (unpublished observation)
where 41.4% of CM users used more than one type of
therapy, or in 2002 or 1997 where, respectively, 33.4%
[43] and 54% [44] of CM users used more than one type
of therapy (as in the present analysis, these studies
counted use of multiple NVNMDS or multiple diet-
based therapies only once each).
This study has several limitations. First, the variables
being investigated were self-reported. The scientific li-
terature suggests that most people tend to under-report
negative health behaviors [45]. Hence, the effects of alco-
hol consumption [46,47] or smoking behavior [48] may
have been underreported in this study. Second, the
cross-sectional nature of the data prevents us from
establishing whether the diagnosis of diabetes actually
occurred prior to and resulted in the diseases/conditions
we considered as complications of diabetes. Thus, it is
likely that for some unknown percent of participants,
non-complications were misclassified as complications.
From our data, we cannot predict how such misclassifica-
tion would impact on our results. These cross-sectional
data also do not let us investigate the possibility of cohort
effects and secular trends in the associations between dia-
betes severity and CM use. Third, the lack of confirmed
diagnoses of type-1 and type-2 diabetes makes some de-
gree of misclassification likely. Based on our criteria for
differentiating between type-1 and type-2 diabetes and on
published NHANES data [49], we can predict that 7-9% of
the cases we classified as type-2 were in fact type-1. Con-
versely, given the increasing prevalence of type-2 diabetes
in youth, we can predict that some unknown proportion
of individuals we classified as probably having type-1 dia-
betes actually had type-2. We sought to more completely
capture the population of individuals with type-2 diabetes
by lowering the cutoff age for differentiating type-1 and
type-2. We found that lowering the cutoff age to less than
10-years old, a cutoff likely to capture almost all, if not all
individuals with type-2 diabetes [34], did not substantially
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be replicated in a dataset that incorporates confirmed
physician diagnosis of diabetes by type and also contains
information on the use of CM. Fourth, it is possible that
additional measures of diabetes severity (as well as other
unexplored factors) explain more of the observed relation-
ships. However, the six measures employed are predictors
of mortality and morbidity in diabetes [50,51]. Fifth, be-
cause our primary focus was to identify factors associated
with the use, versus nonuse, of CM, a dichotomous
dependent variable was utilized for the primary analysis.
By doing so, information on frequency and/or intensity of
use was lost. It may be that substantial differences exist
between heavy and light users of one or more CM modal-
ities [44]. Sixth, it has been found that the use of specific
types of CM therapies is associated with specific personal-
ity styles [52]. These associations might confound our
results if specific personality styles (e.g., “openness” or
“control”) are also related to better diabetes control. Fi-
nally, despite combining data from two very large national
surveys in the United States, the number of respondents
using CM specifically to treat their diabetes was small
(141 respondents, equivalent to 3.4% of individuals with
type-2 diabetes). While this may have increased the
chance of type-2 error (false negatives) in our analyses and
certainly prevented assessment of individual CM thera-
pies, it does not change our confidence in the positive
associations we did observe.
Conclusions
Our results demonstrate that individuals with more se-
vere diabetes are more likely to use CM independent of
sociodemographic factors. Further studies are essential
to determine if CM therapies, either alone or in combi-
nation with conventional approaches, actually improve
clinical outcomes when used to treat/manage diabetes.
Also warranted are studies investigating the cause and
effect relationships underlying the associations between
diabetes severity and CM use. Knowledge of these spe-
cific patterns of use may contribute to tailoring health
education programs for diabetes. For health care provi-
ders, understanding the motivations behind a patient’s
use of CM may assist in the design of an optimal treat-
ment plan [53]. The fact that users of CM appear willing
to take active control of their health [54-56], suggests
that this group of individuals with diabetes may well be
open to additional recommendations toward managing
their disease.
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